Harmony Biosciences Holdings Inc (HRMY)
33.43
+0.39
(+1.18%)
USD |
NASDAQ |
Nov 05, 16:00
33.00
-0.43
(-1.29%)
After-Hours: 20:00
Harmony Biosciences Holdings Total Liabilities (Quarterly): 331.33M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 331.33M |
| June 30, 2024 | 319.80M |
| March 31, 2024 | 331.59M |
| December 31, 2023 | 344.46M |
| September 30, 2023 | 296.43M |
| June 30, 2023 | 275.01M |
| March 31, 2023 | 272.05M |
| December 31, 2022 | 271.03M |
| September 30, 2022 | 299.58M |
| June 30, 2022 | 258.50M |
| Date | Value |
|---|---|
| March 31, 2022 | 249.50M |
| December 31, 2021 | 246.94M |
| September 30, 2021 | 239.07M |
| June 30, 2021 | 233.14M |
| March 31, 2021 | 229.37M |
| December 31, 2020 | 329.89M |
| September 30, 2020 | 225.52M |
| June 30, 2020 | 218.17M |
| March 31, 2020 | 212.78M |
| December 31, 2019 | 118.29M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
118.29M
Minimum
Dec 2019
344.46M
Maximum
Dec 2023
265.12M
Average
264.77M
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 8.116B |
| EyePoint Pharmaceuticals Inc | 95.94M |
| Cassava Sciences Inc | 54.59M |
| Capricor Therapeutics Inc | 26.78M |
| Anavex Life Sciences Corp | 11.75M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 928.14M |
| Shareholders Equity (Quarterly) | 596.80M |
| Debt to Equity Ratio | 0.3064 |
| Current Ratio | 3.239 |
| Net Debt Paydown Yield | 0.08% |